A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder

被引：0
|
作者：
Soyon Lee
Bimal Malhotra
Dana Creanga
Martin Carlsson
Paul Glue
机构：
[1] Rutgers University,Ernest Mario School of Pharmacy
[2] Pfizer Inc,Clinical Pharmacology Department
[3] Pfizer Inc,Statistics Department
[4] Dunedin School of Medicine,undefined
来源：
BMC Medical Research Methodology | / 9卷
关键词：
Stress Urinary Incontinence; Overactive Bladder; Oxybutynin; Tolterodine; Placebo Response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Flavoxate in the symptomatic treatment of overactive bladder: a meta-analysis
    Sweeney, P.
    Mutambirwa, S.
    Van An, N.
    Sharma, J. B.
    Vanamail, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (17) : 3703 - +
  • [42] MIRABEGRON VERSUS TOLTERODINE FOR THE TREATMENT OF OVERACTIVE BLADDER: A META-ANALYSIS OF FIVE RANDOMIZED CONTROLLED TRIALS
    Naser, O.
    Elgebaly, A.
    Elfil, M.
    Mahmoud, A.
    Negida, A.
    Rashad, Y.
    Rashad, M.
    Abd Elsalam, A. E.
    Elkohly, S.
    Abdelrahman, A.
    Gana, B.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S403 - S404
  • [43] Acupuncture for the treatment of overactive bladder: A protocol for systematic review and meta-analysis of randomized controlled trials
    Kim, Jong-In
    Lee, Ju Ah
    Choi, Tae-Young
    Jun, Ji Hee
    Choi, Jiae
    Shin, Byung-Cheul
    Lim, Hyun-Ja
    Lee, Myeong Soo
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2016, 8 (05) : 875 - 878
  • [44] Cost Analysis of Interventions for Antimuscarinic Refractory Patients With Overactive Bladder
    不详
    JOURNAL OF UROLOGY, 2011, 186 (01): : 212 - 212
  • [45] Treatment of Non-neurogenic Overactive Bladder with OnabotulinumtoxinA: Systematic Review and Meta-analysis of Prospective, Randomized, Placebo-controlled Clinical Trials
    Arruda, Raquel Martins
    Takano, Claudia Cristina
    Batista Castelo Girao, Manoel Joao
    Haddad, Jorge Milhem
    Aleixo, Gabriel Francisco
    Castro, Rodrigo Aquino
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2018, 40 (04): : 225 - 231
  • [46] Cost Analysis of Interventions for Antimuscarinic Refractory Patients With Overactive Bladder
    Watanabe, Jonathan H.
    Campbell, Jonathan D.
    Ravelo, Arliene
    Chancellor, Michael B.
    Kowalski, Jonathan
    Sullivan, Sean D.
    UROLOGY, 2010, 76 (04) : 835 - 840
  • [47] Placebo response in trials of drug treatments for cancer-related fatigue: a systematic review, meta-analysis and meta-regression
    Roji, Rocio
    Stone, Patrick
    Ricciardi, Federico
    Candy, Bridget
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2020, 10 (04) : 385 - 394
  • [48] The placebo response in trials of drug treatments for cancer-related fatigue: A systematic review, meta-analysis and meta-regression
    Buqueras, Maria del Rocio Roji
    Stone, Patrick
    Ricciardi, Federico
    Candy, Bridget
    BRITISH JOURNAL OF CANCER, 2019, 121 : 27 - 27
  • [49] Comparative Efficacy of Neuromodulation Technologies for Overactive Bladder in Adults: A Network Meta-Analysis of Randomized Controlled Trials
    Huang, Jiapeng
    Fan, Ye
    Zhao, Kehong
    Yang, Chunlan
    Zhao, Ziqi
    Chen, Yin
    Yang, Jiaen
    Wang, Tingting
    Qu, Yun
    NEUROMODULATION, 2023, 26 (08): : 1535 - 1548
  • [50] Re: Systematic Review and Meta-Analysis: Do Clinical Trials Testing Antimuscarinic Agents for Overactive Bladder Adequately Measure Central Nervous System Adverse Events? Editorial Comment
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2012, 187 (01): : 209 - 210
12345